Saturday, May 30, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle

"granules-india-limited"

  • Granules India Limited receives final approval from USFDA for its new drug

    Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients aged six years and older, as well as for Moderate to Severe Binge Eating Disorder (BED) in adults

Latest News

  • KTR demands explanation from Central Government over CBSE marks fiasco

    1 min ago
  • Maratha Reservation: Manoj Jarange Patil commences indefinite hunger strike in Maha village

    8 mins ago
  • Parkinson’s struggle meets AI innovation as London singer uses tech to finish new album

    15 mins ago
  • Armed forces bring Kasauli fire under control

    20 mins ago
  • CDS Gen Chauhan releases doctrine on joint air defence

    31 mins ago
  • Fire breaks out at Tirumala Theatre in Karimnagar, property damaged

    35 mins ago
  • India’s tobacco quitline receives nearly 1 crore calls in last decade, helps 2.32 lakh users quit

    36 mins ago
  • Filmmaker Vishal Bhardwaj recalls deep bond with late poet Bashir Badr

    41 mins ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam